Your browser doesn't support javascript.
loading
Genetic susceptibility loci of idiopathic interstitial pneumonia do not represent risk for systemic sclerosis: a case control study in Caucasian patients.
Wu, Minghua; Assassi, Shervin; Salazar, Gloria A; Pedroza, Claudia; Gorlova, Olga Y; Chen, Wei V; Charles, Julio; Taing, Miranda L; Liao, Kelley; Wigley, Fredrick M; Hummers, Laura K; Shah, Ami A; Hinchcliff, Monique; Khanna, Dinesh; Schiopu, Elena; Phillips, Kristine; Furst, Daniel E; Steen, Virginia; Baron, Murray; Hudson, Marie; Zhou, Xiaodong; Pope, Janet; Jones, Niall; Docherty, Peter; Khalidi, Nader A; Robinson, David; Simms, Robert W; Silver, Richard M; Frech, Tracy M; Fessler, Barri J; Fritzler, Marvin J; Molitor, Jerry A; Segal, Barbara M; Movahedian, Malahat; Martín, Javier; Varga, John; Mayes, Maureen D.
Afiliação
  • Wu M; Division of Rheumatology and Clinical Immunogenetics, Department of Internal Medicine, University of Texas McGovern Medical School at Houston, 6431 Fannin Street, Houston, TX, 77030, USA. Minghua.wu@uth.tmc.edu.
  • Assassi S; Division of Rheumatology and Clinical Immunogenetics, Department of Internal Medicine, University of Texas McGovern Medical School at Houston, 6431 Fannin Street, Houston, TX, 77030, USA. Shervin.assassi@uth.tmc.edu.
  • Salazar GA; Division of Rheumatology and Clinical Immunogenetics, Department of Internal Medicine, University of Texas McGovern Medical School at Houston, 6431 Fannin Street, Houston, TX, 77030, USA. Gloria.SalazarCintora@uth.tmc.edu.
  • Pedroza C; Department of Pediatrics, The University of Texas Mcgovern Medical School at Houston, 6431 Fannin Street, Houston, TX, 77030, USA. Claudia.Pedroza@uth.tmc.edu.
  • Gorlova OY; Department of Community and Family Medicine, Geisel School of Medicine at Dartmouth, 1 Rope Ferry Road, Hanover, NH, 03755, USA. Olga.Y.Gorlova@dartmouth.edu.
  • Chen WV; Department of Community and Family Medicine, Geisel School of Medicine at Dartmouth, 1 Rope Ferry Road, Hanover, NH, 03755, USA. vwchen001@gmail.com.
  • Charles J; Division of Rheumatology and Clinical Immunogenetics, Department of Internal Medicine, University of Texas McGovern Medical School at Houston, 6431 Fannin Street, Houston, TX, 77030, USA. Julio.Charles@uth.tmc.edu.
  • Taing ML; Division of Rheumatology and Clinical Immunogenetics, Department of Internal Medicine, University of Texas McGovern Medical School at Houston, 6431 Fannin Street, Houston, TX, 77030, USA. miranda.l.taing@uth.tmc.edu.
  • Liao K; Division of Rheumatology and Clinical Immunogenetics, Department of Internal Medicine, University of Texas McGovern Medical School at Houston, 6431 Fannin Street, Houston, TX, 77030, USA. Kelley.Liao@uth.tmc.edu.
  • Wigley FM; Division of Rheumatology, Johns Hopkins University School of Medicine, 5501 Hopkins Bayview circle, Baltimore, MD, 21224, USA. fwig@jhmi.edu.
  • Hummers LK; Division of Rheumatology, Johns Hopkins University School of Medicine, 5501 Hopkins Bayview circle, Baltimore, MD, 21224, USA. lhummers@jhmi.edu.
  • Shah AA; Division of Rheumatology, Johns Hopkins University School of Medicine, 5501 Hopkins Bayview circle, Baltimore, MD, 21224, USA. Ami.Shah@jhmi.edu.
  • Hinchcliff M; Division of Rheumatology, Northwestern University Feinberg School of Medicine, 240 East Huron Street, Chicago, IL, 60611, USA. m-hinchcliff@northwestern.edu.
  • Khanna D; Department of Internal Medicine, Division of Rheumatology, University of Michigan Health Center, 300 North Ingalls Street, Ann Arbor, MI, 48109, USA. khannad@med.umich.edu.
  • Schiopu E; Department of Internal Medicine, Division of Rheumatology, University of Michigan Health Center, 300 North Ingalls Street, Ann Arbor, MI, 48109, USA. eschiopu@med.umich.edu.
  • Phillips K; Department of Internal Medicine, Division of Rheumatology, University of Michigan Health Center, 300 North Ingalls Street, Ann Arbor, MI, 48109, USA. kphill@med.umich.edu.
  • Furst DE; Division of Rheumatology, University of California Los Angeles, 1000 Veterans Avenue, Los Angeles, CA, 90024, USA. DEFurst@mednet.ucla.edu.
  • Steen V; Division of Rheumatology, Georgetown University Medical Center, 3800 Reservoir Road, Washington, MD, 20007, USA. steenv@georgetown.edu.
  • Baron M; Division of Rheumatology, McGill University, 1650 Cedar Avenue, Montreal, QC, H3G 1A4, Canada. murray.baron@jgh.mcgill.ca.
  • Hudson M; Division of Rheumatology, McGill University, 1650 Cedar Avenue, Montreal, QC, H3G 1A4, Canada. marie.hudson@mcgill.ca.
  • Zhou X; Division of Rheumatology and Clinical Immunogenetics, Department of Internal Medicine, University of Texas McGovern Medical School at Houston, 6431 Fannin Street, Houston, TX, 77030, USA. xiaodong.zhou@uth.tmc.edu.
  • Pope J; Division of Rheumatology, St. Joseph's Health Care, University of Western Ontario, 268 Grosvenor Street, London, ON, Canada. janet.pope@sjhc.london.on.ca.
  • Jones N; Division of Rheumatology, University of Alberta, 11405-87 Avenue, Edmonton, AB, T6G 1C9, Canada. sameitjones@shaw.ca.
  • Docherty P; Division of Rheumatology, Moncton Hospital, 135 MacBeath Avenue, Moncton, NB, E1C 6Z8, Canada. pedocher@serha.ca.
  • Khalidi NA; Division of Rheumatology, McMaster University at Hamilton, 1280 Main Street West, Hamilton, ON, L8S 4L8, Canada. naderkhalidi@sympatico.ca.
  • Robinson D; Division of Rheumatology, University of Manitoba, 820 Sherbrook Street, Winnipeg, MB, R3A 1R9, Canada. drobinson@hsc.mb.ca.
  • Simms RW; Division of Rheumatology, Boston University School of Medicine, 72 East Concord Street, Boston, MA, 02118, USA. rsimms@bu.edu.
  • Silver RM; Division of Rheumatology, Medical University of South Carolina, 171 Ashley Avenue, Charleston, SC, 29425, USA. silverr@musc.edu.
  • Frech TM; Division of Rheumatology, University of Utah, 30 North 1900 East, Salt Lake City, UT, 84132, USA. Tracy.frech@hsc.utah.edu.
  • Fessler BJ; Division of Clinical Immunology and Rheumatology, University of Alabama at Birmingham, 1825 University Boulevard, Birmingham, AB, 35294, USA. bjf@uab.edu.
  • Fritzler MJ; Division of Rheumatology, University of Calgary Cumming School of Medicine, 3330 Hospital Drive NW, Calgary, AB, T2N 4N1, Canada. fritzler@ucalgary.ca.
  • Molitor JA; Division of Rheumatology, University of Minnesota, 420 Delaware Street SE, Minneapolis, MN, 55455, USA. jmolitor@umn.edu.
  • Segal BM; Division of Rheumatology, University of Minnesota, 420 Delaware Street SE, Minneapolis, MN, 55455, USA. Segal017@umn.edu.
  • Movahedian M; Division of Rheumatology and Clinical Immunogenetics, Department of Internal Medicine, University of Texas McGovern Medical School at Houston, 6431 Fannin Street, Houston, TX, 77030, USA. Malahat.Movahedian@uth.tmc.edu.
  • Martín J; Instituto de Parasitología y Biomedicina López-Neyra, Consejo Superior de Investigaciones Cientificas, C/Ventanilla 11, 18001, Granada, Spain. martin@ipb.csic.es.
  • Varga J; Division of Rheumatology, Northwestern University Feinberg School of Medicine, 240 East Huron Street, Chicago, IL, 60611, USA. j-varga@northwetern.edu.
  • Mayes MD; Division of Rheumatology and Clinical Immunogenetics, Department of Internal Medicine, University of Texas McGovern Medical School at Houston, 6431 Fannin Street, Houston, TX, 77030, USA. Maureen.D.Mayes@uth.tmc.edu.
Arthritis Res Ther ; 18: 20, 2016 Jan 20.
Article em En | MEDLINE | ID: mdl-26792595
ABSTRACT

BACKGROUND:

Systemic sclerosis (SSc)-related interstitial lung disease (ILD) has phenotypic similarities to lung involvement in idiopathic interstitial pneumonia (IIP). We aimed to assess whether genetic susceptibility loci recently identified in the large IIP genome-wide association studies (GWASs) were also risk loci for SSc overall or severity of ILD in SSc.

METHODS:

A total of 2571 SSc patients and 4500 healthy controls were investigated from the US discovery GWAS and additional US replication cohorts. Thirteen IIP-related selected single nucleotide polymorphisms (SNPs) were genotyped and analyzed for their association with SSc.

RESULTS:

We found an association of SSc with the SNP rs6793295 in the LRRC34 gene (OR = 1.14, CI 95 % 1.03 to 1.25, p value = 0.009) and rs11191865 in the OBFC1 gene (OR = 1.09, CI 95 % 1.00 to 1.19, p value = 0.043) in the discovery cohort. Additionally, rs7934606 in MUC2 (OR = 1.24, CI 95 % 1.01 to 1.52, p value = 0.037) was associated with SSc-ILD defined by imaging. However, these associations failed to replicate in the validation cohort. Furthermore, SNPs rs2076295 in DSP (ß = -2.29, CI 95 % -3.85 to -0.74, p value = 0.004) rs17690703 in SPPL2C (ß = 2.04, CI 95 % 0.21 to 3.88, p value = 0.029) and rs1981997 in MAPT (ß = 2.26, CI 95 % 0.35 to 4.17, p value = 0.02) were associated with percent predicted forced vital capacity (FVC%) even after adjusting for the anti-topoisomerase (ATA)-positive subset. However, these associations also did not replicate in the validation cohort.

CONCLUSIONS:

Our results add new evidence that SSc and SSc-related ILD are genetically distinct from IIP, although they share phenotypic similarities.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Escleroderma Sistêmico / Predisposição Genética para Doença / População Branca / Pneumonias Intersticiais Idiopáticas / Loci Gênicos Tipo de estudo: Diagnostic_studies / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2016 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Escleroderma Sistêmico / Predisposição Genética para Doença / População Branca / Pneumonias Intersticiais Idiopáticas / Loci Gênicos Tipo de estudo: Diagnostic_studies / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2016 Tipo de documento: Article